STATE STREET CORP - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$148,285
-25.1%
56,814
+2.7%
0.00%
Q2 2023$197,981
+68.6%
55,302
+2.7%
0.00%
Q1 2023$117,428
-90.4%
53,866
-47.2%
0.00%
Q4 2022$1,226,892
+302.3%
101,986
+117.0%
0.00%
Q3 2022$305,000
+44.5%
46,992
+2.1%
0.00%
Q2 2022$211,000
-95.5%
46,009
-91.4%
0.00%
Q1 2022$4,651,000
-36.4%
537,670
+5.0%
0.00%
Q4 2021$7,315,000
-31.8%
512,246
+5.0%
0.00%
-100.0%
Q3 2021$10,726,000
+127.8%
487,999
+38.7%
0.00%
Q2 2021$4,709,000351,9200.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,355,925$2,955,9172.56%
Susquehanna International Group Ltd. 113,526$247,4870.14%
XTX Topco Ltd 151,620$330,5320.07%
Corsair Capital Management 47,256$103,0180.04%
Diametric Capital, LP 14,314$31,2050.02%
Draper Asset Management, LLC 5,320$11,5980.02%
ETF MANAGERS GROUP, LLC 68,940$150,2890.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$12,2670.00%
TWO SIGMA INVESTMENTS, LP 506,255$1,103,6360.00%
Apollon Wealth Management, LLC 20,000$43,6000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders